Reliability, Validity and Responsiveness of the Upright Motor Control Test in Patients With Stroke

Impaired motor function is common after stroke. Individuals with stroke often exhibit synergic pattern that disturb daily function. It is crucial to identify the movement impairment in the clinical settings. Upright Motor Control Test (UMCT) is one of the tests developed to assess the selective movement control and functional strength in people with central nervous disorders. It can be used to reflect the impairment of motor function and evaluate changes of performance after treatment. Yet is little to know the clinimetrics of the UMCT on clinical utility. To date, only few researches explore that UMCT has some construct and criterion validity.

Therefore, this study aims to 1) establish the inter-rater reliability to administer the UMCT. 2) explore the correlation between the Fugl-Meyer Assessment of Motor Recovery after Stroke (FMA) and UMCT. 3). investigate whether the UMCT is able to predict the walking ability in patients with stroke.

Study Overview

• Status: Terminated
• Conditions: Stroke

• Study Type: Observational
• Enrollment (Actual): 67

Contacts and Locations

Study Locations

• Taiwan
  • New Taipei City, Taiwan
    • Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Adults with first-ever, unilateral cerebral stroke within one month

Description

Inclusion Criteria:

• First-ever, unilateral cerebral stroke within one month
• Being able to maintain standing for more than 10 seconds

Exclusion Criteria:

• Could not follow commands
• Deformity or fracture of lower limb
• Less than 20 years old

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Upright Motor Control Test	6-18; higher score means better isolated joint control.	1 month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fugl-Meyer Assessment of Motor Recovery after Stroke	UE scale:0-66; LE scale:0-34; higher score means better motor function.	1 month

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
10 Meter Walk Test	Test the time required to complete 10 meters of walking.	1, 3, 6, and 12 month
6-Minutes-Waking-Test	Record the distance in six-minute walking.	1, 3, 6, and 12 month
Berg Balance Scale	score: 0-56; lower score means higher risk of fall.	1, 3, 6, and 12 month
Stroke Rehabilitation Assessment of Movement Measure	UE: 0-20; LE: 0-20: Mobility: 0-30; higher score indicated better motor function.	1, 3, 6, and 12 month

Collaborators and Investigators

• Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
• Investigators: Principal Investigator: Bo-Jhen Chen, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Study record dates

Study Major Dates

• Study Start (Actual): February 6, 2018
• Primary Completion (Actual): June 30, 2021
• Study Completion (Actual): June 30, 2021

Study Registration Dates

• First Submitted: March 14, 2018
• First Submitted That Met QC Criteria: March 14, 2018
• First Posted (Actual): March 20, 2018

Study Record Updates

• Last Update Posted (Actual): March 16, 2022
• Last Update Submitted That Met QC Criteria: March 1, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Stroke
• Other Study ID Numbers: 06-XD13-045

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No